CAC
MRNA icon

Certified Advisory Corp’s Moderna MRNA Stock Holding History

Certified Advisory Corp’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-253
Closed -$33K – 531
2021
Q1 		$33K Buy
+253
New +$36.7K 0.01% 408
2020
Q2 		$2K Hold
33
– – ﹤0.01% 703
2020
Q1 		$1K Buy
+33
New +$759 ﹤0.01% 739

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Certified Advisory Corp's MRNA Position: Q2 2021 in Review

Certified Advisory Corp sold out of Moderna (MRNA) in Q2 2021, closing a stake of 253 shares — an estimated $33K sold.

Certified Advisory Corp first reported a position in MRNA in Q1 2020 and held it in 3 quarters. The position peaked at $33K in Q1 2021. 903 funds tracked by Wall St. Rank hold MRNA as of Q2 2021.

  • Certified Advisory Corp reported no remaining Moderna position as of Q2 2021 after selling out during the quarter.
  • Certified Advisory Corp sold 253 Moderna shares in Q2 2021, an estimated $33K.
  • Certified Advisory Corp first reported a position in Moderna in Q1 2020 and held it in 3 quarters.
  • Certified Advisory Corp's Moderna position peaked at $33K in Q1 2021.
  • 903 funds tracked by Wall St. Rank held Moderna as of Q2 2021.

Based on Certified Advisory Corp's 13F filing for Q2 2021, filed 16 Aug 2021.